Related Experiment Video
Updated: Jul 14, 2026
12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Low-dose hormonal contraception after liver transplantation
Z Jabiry-Zieniewicz1, K Bobrowska, P Kaminski
1First Department of Obstetrics and Gynecology, Medical University of Warsaw, Starynkiewicza Sq. 1/3, Warsaw 02-015, Poland.
Transplantation Proceedings
|June 21, 2007
Summary
Hormonal contraceptives are safe and effective for women after liver transplantation, with no impact on graft function or significant side effects. Further long-term studies are recommended for comprehensive safety assessment.
Area of Science:
- Hepatology
- Transplantation Medicine
- Reproductive Endocrinology
Background:
- End-stage liver failure significantly impairs fertility.
- Liver transplantation can restore menstrual function, necessitating contraception for non-pregnant patients.
- Hormonal contraception is a critical consideration for women of reproductive age post-liver transplant.
Purpose of the Study:
- To evaluate the tolerability and safety of hormonal contraceptives in female liver transplant recipients.
- To assess the impact of hormonal contraception on liver graft function and patient health parameters.
Main Methods:
- Retrospective analysis of 15 female liver transplant recipients using hormonal contraceptives for at least 12 months.
- Monitoring of liver function tests, fasting glucose, BMI, and blood pressure at baseline and follow-up intervals.
- Documentation of any reported side effects during regular examinations.
Main Results:
- No pregnancies or graft rejections occurred during hormonal contraceptive therapy.
- Biochemical liver function parameters, blood pressure, and BMI remained stable without significant changes.
- No patients discontinued hormonal contraception due to medical indications, indicating good tolerability.
Conclusions:
- Hormonal contraception is effective and well-tolerated in stable liver transplant recipients.
- Hormonal contraceptives did not appear to negatively affect liver graft function.
- Long-term prospective studies are needed to fully establish the safety profile of hormonal contraception in this population.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...